Quanterix Corp (QTRX): Capital Expenditures
$2.61M
Year ended 2025-12-31
$762.0K
Trailing 12 months to 2026-06-30
-39.2%
3-year compound annual growth
-7.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.61M | -22.4% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $3.37M | -12.3% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $3.84M | -66.9% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $11.61M | -15.1% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $13.68M | +248.0% | 2024-12-26, From 2021-01-01 |
| 2020-12-31 | $3.93M | -63.8% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $10.85M | +614.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $1.52M | +34.1% | 2021-03-05, From 2018-01-01 |
| 2017-12-31 | $1.13M | +115.2% | 2020-03-13, From 2017-01-01 |
| 2016-12-31 | $526.0K | n/a | 2019-03-18, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $4.08M | +15.9% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $1.26M | -52.4% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $955.0K | +58.6% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $850.0K | -37.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $3.28M | -19.1% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $5.93M | -52.1% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $326.0K | +46.2% |
Compare QTRX, PACB, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗